Cargando…

Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron Variant

The SARS-CoV-2 Omicron variant is characterized by substantial changes in the antigenic structure of the Spike (S) protein. Therefore, antibodies induced by primary Omicron infection lack neutralizing activity against earlier variants. In this study, we analyzed whether these antigenic changes impac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Springer, David Niklas, Perkmann, Thomas, Jani, Claudia Maria, Mucher, Patrick, Prüger, Katja, Marculescu, Rodrig, Reuberger, Elisabeth, Camp, Jeremy Vann, Graninger, Marianne, Borsodi, Christian, Deutsch, Josef, Lammel, Oliver, Aberle, Stephan Walter, Puchhammer-Stöckl, Elisabeth, Haslacher, Helmuth, Höltl, Eva, Aberle, Judith Helene, Stiasny, Karin, Weseslindtner, Lukas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603218/ https://www.ncbi.nlm.nih.gov/pubmed/36005839 http://dx.doi.org/10.1128/spectrum.02129-22

Ejemplares similares

Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference
por: Graninger, Marianne, et al.
Publicado: (2023)

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
por: Medits, Iris, et al.
Publicado: (2022)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
por: Springer, David Niklas, et al.
Publicado: (2023)

Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
por: Graninger, Marianne, et al.
Publicado: (2022)

Breakthrough infections with SARS-CoV-2 omicron efficiently boost antibodies from previous BNT162b2 vaccinations
por: Perkmann, Thomas, et al.
Publicado: (2023)

Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
por: Springer, David N., et al.
Publicado: (2023)

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
por: Perkmann, Thomas, et al.
Publicado: (2021)

Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays
por: Semmler, Georg, et al.
Publicado: (2021)

Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19
por: Vietzen, Hannes, et al.
Publicado: (2021)

Dissection of the NKG2C NK cell response against Puumala Orthohantavirus
por: Vietzen, Hannes, et al.
Publicado: (2021)

Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology
por: Perkmann, Thomas, et al.
Publicado: (2023)

Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria
por: Redlberger-Fritz, Monika, et al.
Publicado: (2021)

Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity
por: Koblischke, Maximilian, et al.
Publicado: (2020)

Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs
por: Traugott, Marianna Theresia, et al.
Publicado: (2020)

RT-PCR based SARS-CoV-2 variant screening assays require careful quality control
por: Camp, Jeremy V., et al.
Publicado: (2021)

Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against Omicron
por: Sieber, Justyna, et al.
Publicado: (2022)

Monitoring of Sotrovimab-Levels as Pre-Exposure Prophylaxis in Kidney Transplant Recipients Not Responding to SARS-CoV-2 Vaccines
por: Aschauer, Constantin, et al.
Publicado: (2023)

25(OH)D and 1,25(OH)D vitamin D fails to predict sepsis and mortality in a prospective cohort study
por: Ratzinger, Franz, et al.
Publicado: (2017)

The First Case of Usutu Virus Neuroinvasive Disease in Austria, 2021
por: Graninger, Marianne, et al.
Publicado: (2022)

Design of external quality assessment schemes and definition of the roles of their providers in future epidemics
por: Buchta, Christoph, et al.
Publicado: (2023)

Serum antibody response to BNT162b2 after natural SARS‐CoV‐2 infection
por: Perkmann, Thomas, et al.
Publicado: (2021)

First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences
por: Görzer, I., et al.
Publicado: (2020)

SARS-CoV-2 Omicron BA.1/BA.2 Neutralization up to 8 Weeks After PrEP With Sotrovimab or Cilgavimab/Tixagevimab
por: Stiasny, Karin, et al.
Publicado: (2022)

Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222
por: Perkmann, Thomas, et al.
Publicado: (2021)

Performance of Four IgM Antibody Assays in the Diagnosis of Measles Virus Primary Infection and Cases with a Serological Profile Indicating Reinfection
por: Semmler, Georg, et al.
Publicado: (2021)

Converting to an international unit system improves harmonization of results for SARS-CoV-2 quantification: Results from multiple external quality assessments
por: Buchta, Christoph, et al.
Publicado: (2023)

Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients
por: Graninger, Marianne, et al.
Publicado: (2023)

Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals
por: Aichelburg, Maximilian C., et al.
Publicado: (2015)

Human cytomegalovirus strain diversity and dynamics reveal the donor lung as a major contributor after transplantation
por: Külekci, Büsra, et al.
Publicado: (2022)

SARS-CoV-2 Infections in “less visible” Hospital Staff: The Roles and Safety of Environmental Services and Allied Health Professionals
por: Jensen, Sebastian, et al.
Publicado: (2023)

Chronic Lymphocytic Leukemia Patients Have a Preserved Cytomegalovirus-Specific Antibody Response despite Progressive Hypogammaglobulinemia
por: Vanura, Katrina, et al.
Publicado: (2013)

Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown
por: Breyer, Marie-Kathrin, et al.
Publicado: (2021)

Immune Response after mRNA COVID-19 Vaccination in Lung Transplant Recipients: A 6-Month Follow-Up
por: Tobudic, Selma, et al.
Publicado: (2022)

Spike Protein Antibodies Mediate the Apparent Correlation between SARS-CoV-2 Nucleocapsid Antibodies and Neutralization Test Results
por: Perkmann, Thomas, et al.
Publicado: (2021)

The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study
por: Perkmann, Thomas, et al.
Publicado: (2022)

Standardisation and controls, why can’t we overcome the hurdles?
por: Niesters, Hubert G.M., et al.
Publicado: (2004)

Basal myokine levels are associated with quality of life and depressed mood in older adults
por: Mucher, Patrick, et al.
Publicado: (2021)

Successful management of the first reported case in Austria of COVID-19 with ARDS
por: Seitz, T., et al.
Publicado: (2020)

Association between Epstein‐Barr‐Virus reactivation and development of Long‐COVID fatigue
por: Rohrhofer, Johanna, et al.
Publicado: (2022)

High-affinity FcγRIIIa genetic variants and potent NK cell-mediated antibody-dependent cellular cytotoxicity (ADCC) responses contributing to severe COVID-19
por: Vietzen, Hannes, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sisck6hepln7vo7h5husn2fod5